Cited by 44Influenza Virus Research StudiesPneumonia and Respiratory InfectionsRespiratory viral infections research

The effects of live attenuated influenza vaccine on nasopharyngeal bacteria in healthy 2 to 4 year olds. a randomized controlled trial

Open access
Thors, Valtyr, Christensen, Hannah, Morales-Aza, Begonia, Vipond, Ian, Muir, Peter, Finn, Adam·2016·American Journal of Respiratory and Critical Care Medicine

Abstract

RATIONALE: Viral infections of the upper respiratory tract may influence the commensal nasopharyngeal bacteria. Changes in the bacterial niche could affect transmission dynamics. Attenuated vaccine viruses can be used to investigate this empirically in humans. OBJECTIVES: To study the effects of mild viral upper respiratory infections on nasopharyngeal bacterial colonization using live attenuated influenza vaccine (LAIV) as a surrogate. METHODS: We used trivalent LAIV to evaluate the effects of viral infection on bacterial carriage and density of Streptococcus pneumoniae, Moraxella catarrhalis, Haemophilus influenzae, and Staphylococcus aureus. A total of 151 healthy children were randomized 1:1 to receive the vaccine starting either at recruitment (n = 74) or 28 days later (n = 77) in a stepped wedge fashion, allowing comparisons between recipients and nonrecipients as well as whole-group comparisons pre- and postvaccination. Bacterial carriage and density were determined using quantitative polymerase chain reaction assays. MEASUREMENTS AND MAIN RESULTS: A total of 151 children were recruited, 77 in the LAIV group and 74 in the control group. LAIV recipients (n = 63 analyzed) showed an apparent transient increase in H. influenzae carriage but no further significant differences in carriage prevalence of the four bacterial species compared with controls (n = 72 analyzed). S. pneumoniae density was substantially higher in vaccine recipients (16,687 vs. 1935 gene copies per milliliter) 28 days after the first dose (P < 0.001). Whole-group multivariable analysis (prevaccine, after one dose, and after two doses) also showed increases in density of other species and H. influenzae carriage prevalence. CONCLUSIONS: In the absence of any safety signals despite widespread use of the vaccine, these findings suggest that bacterial density, and thus transmission rates among children and to people in other age groups, may rise following attenuated influenza infections without associated clinical disease. LAIV could therefore be used as an experimental tool to elucidate the dynamics of transmission of nasopharyngeal bacteria.

Integrity signals

Registry

Crossref · 10.1164/rccm.201510-2000oc

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Thors, V., Christensen, H., Morales-Aza, B., Vipond, I., Muir, P., & Finn, A.
Affiliations
  • University of Bristol (GB)
  • School of Cellular and Molecular Medicine and
  • Public Health England (GB)
Corresponding author
Thors, Valtyr
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2016-06
Volume
193
Issue
12
Pages
1401-1409
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2229704027
Cited by
44
References
23
Citations by year
2026: 3 · 2025: 2 · 2024: 6 · 2023: 3 · 2022: 3 · 2021: 3 · 2020: 2 · 2019: 7 · 2018: 9 · 2017: 5 · 2016: 1
FWCI
6.88
Type
journal article
Language
en
Open access
Locations
  • American Journal of Respiratory and Critical Care Medicine (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Bristol Research (University of Bristol) (publishedVersion, other-oa)
  • Explore Bristol Research (acceptedVersion, other-oa)
Funders
National Institute for Health Research Health Protection Research Unit
Topics
  • Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
  • Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
  • Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
Keywords
live attenuated influenza vaccine, nasopharyngeal bacteria, Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, bacterial carriage, bacterial density, upper respiratory viral infection, bacterial transmission, children, vaccine safety
MeSH terms
Moraxella catarrhalis, Carrier State, Child, Preschool, Female, Haemophilus influenzae, Humans, Influenza, Human, Influenza Vaccines, Male, Nasopharynx, Staphylococcus aureus, Streptococcus pneumoniae, Vaccines, Attenuated, Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review